Royalty Period. The royalty set forth in Section 7.1 will be payable during a period which shall commence on the Effective Date and shall continue on a country-by-country, Product-by- Product basis, for the longer of: (a) fifteen (15) years from the date of the First Commercial Sale of such Product in such country; and (b) until the last to expire of the Ramot Patents or Joint Patents in such country (the "Royalty Period").
Royalty Period. The royalty payments set forth above shall be payable for each Licensed Product on a product-by-product and country-by-country basis from the time of First Commercial Sale of Licensed Product in such country until the later of (i) [**] years from the time of First Commercial Sale of Licensed Product in such country or (ii) until the last to expire patent containing a Valid Claim providing marketing exclusivity with respect to such Licensed Product.
Royalty Period. Licensee’s obligation to pay royalties to GenuPro under Section 5.03 shall begin, on a country by country basis, upon the date of the First Commercial Sale in such country of such Licensee’s Licensed Product and shall end upon termination of sale of the Licensed Product in such country.
Royalty Period. For clarity, royalty tiers pursuant to Section 5.5.1(a) shall be calculated based on aggregate Net Sales of each Product in the applicable Pfizer Year of the applicable Royalty Period. Royalties on each Product at the rates set forth above shall continue on a country-by-country basis until the expiration of the later of: (i) the last-to-expire Valid Patent Claim; or (ii) a period of [**] after First Commercial Sale of such Product in such country (the “Royalty Period”). Upon expiration of the Royalty Period with respect to any Product in any country, subject to fulfillment or all relevant royalty obligations hereunder. Pfizer shall have a fully paid-up, perpetual and irrevocable right to continue to make, use and sell such Product in such country.
Royalty Period. The obligation to pay royalties under Section 5.1 -------------- shall continue for the following periods:
(A) With respect to sales of LICENSED PRODUCTS subject to such royalties, except as otherwise set forth in Section 5.7 hereof, for the life of such patents until the last of said patent rights covering such products, its use or its manufacturing expires, after which LICENSEE's license under Article 2 above shall become fully paid-up and royalty-free.
(B) With respect to sales of LICENSED PRODUCTS subject to such royalties which make use of all or a portion of the TECHNOLOGY which are not covered by PATENT RIGHTS, for a period of five (5) years from the date of first sale of such LICENSED PRODUCT, after which time LICENSEE's license under Article 2 above shall become fully paid-up and royalty free. Notwithstanding the foregoing, in the event that the TECHNOLOGY used in a LICENSED PRODUCT comes into the public domain through no act of LICENSEE, LICENSEE's license under Article 2 above shall become fully paid-up and royalty free.
Royalty Period. Commencing on the date of the closing of the Offering and ending upon the expiration of copyright.
Royalty Period. (a) In respect of Products for which a royalty is due, Xxxxxxx'x obligation to pay royalties to Rigel shall be for a period of ten (10) years, on a Product-by-Product basis, from the Date of First Sale of each such Product.
(b) For the purposes of determining whether royalties are due hereunder, different dosage forms of a Product shall not be considered different Products provided that different dosage forms contain the same active ingredient.
(c) Upon termination of the royalty payment obligation, Xxxxxxx shall thereafter have in perpetuity a royalty-free, non-exclusive license to make, have made, use, sell, have sold, and import such Products hereunder, without any accounting to Rigel.
Royalty Period. PII’s obligation to pay royalties to RBX under Section 5.04 shall apply on a Licensed Product-by-Licensed Product basis and shall begin, on a country by country basis, upon the date of the First Commercial Sale in such country of such Licensed Product and shall end upon termination of sale of the Licensed Product in such country.
Royalty Period. The accounting for royalties under this Article shall be on the basis of three-month periods beginning three months from the Commencement Date. Each three-month period is called in this Agreement a "Royalty Period”.
Royalty Period. 42 SECTION 7 -- BUSINESS RECORDS/PAYMENTS............................................................................44
